When you think of heart health, you likely picture cholesterol checks or blood pressure readings. However, a liver function test is equally essential in understanding your metabolic landscape.
This panel of blood tests measures specific enzymes and proteins in your blood, offering a window into how well your liver is performing its job—including regulating the fats and sugars that circulate in your bloodstream.
The liver is your body’s metabolic engine. It processes everything you eat and drink, manages cholesterol production, and filters toxins. Recent insights from the American Heart Association suggest that liver health and heart health are inextricably linked; when the liver struggles, the cardiovascular system often bears the burden.
In this guide, we explain what your results mean, how liver dysfunction impacts your arteries, and actionable steps you can take to protect both organs.
How Your Liver Protects Your Heart
Your liver does not operate in isolation. It acts as the central processing unit for your metabolism. When liver function is compromised, it triggers a domino effect that often ends in cardiovascular strain.
The Liver as the Metabolic Engine
Every time you eat, your liver decides what to do with the nutrients. It stores glucose as glycogen for quick energy and converts excess calories into fatty acids. In a healthy state, this balance is precise.
However, when the liver is overwhelmed—often by high sugar or saturated fat intake—it begins to accumulate fat within its own cells, a condition known as steatosis. This fat accumulation disrupts the body’s insulin sensitivity, often serving as the first warning sign of metabolic syndrome.
Cholesterol Regulation
A common misconception is that cholesterol comes primarily from food. In reality, your liver produces approximately 80% of the cholesterol your body needs to build cells and hormones. Its role is dual:
- Production: It synthesizes cholesterol based on your body’s demands.
- Clearance: More importantly, the liver removes LDL (“bad”) cholesterol from the bloodstream via specific receptors.
If a liver function test indicates distress or inflammation, the liver’s ability to clear LDL cholesterol may be impaired. This leads to higher circulating levels of LDL, accelerating the buildup of plaque in your heart’s arteries (atherosclerosis).
The MASLD Link
Medical terminology has recently evolved to better reflect the root cause of liver disease. Metabolically Dysfunctional-Associated Steatotic Liver Disease (MASLD)—formerly known as Non-Alcoholic Fatty Liver Disease (NAFLD)—is now recognized as a leading risk factor for heart disease.
According to the American Association for the Study of Liver Diseases (AASLD), patients with MASLD are at a significantly higher risk for cardiovascular events than for liver failure itself.
This is because a fatty liver releases inflammatory signals (cytokines) into the blood, which can damage blood vessels and promote clotting throughout the body.
Understanding Your Liver Function Test Panel
A standard liver function test panel measures several biomarkers. While looking at your lab report can be confusing, understanding these key components helps you grasp the story they tell about your metabolic health.
Alanine Transaminase (ALT) & Aspartate Transaminase (AST)
These are the most common markers you will see. ALT and AST are enzymes normally found inside liver cells, where they help process proteins.
- The Leak: When liver cells are injured or inflamed (due to fat accumulation, viruses, or toxins), these enzymes “leak” into the bloodstream.
- The Heart Connection: Elevated ALT is increasingly recognized as a marker for metabolic syndrome. Research suggests that high ALT levels often correlate with insulin resistance and a higher risk of developing coronary heart disease.
Alkaline Phosphatase (ALP) & Gamma-Glutamyl Transferase (GGT)
These enzymes primarily relate to the bile ducts—the plumbing system of the liver.
- ALP: High levels can indicate blocked bile ducts or bone issues (Pregnancy can also elevate the levels of ALP. This is a normal process, not a pathological one).
- GGT: This is a sensitive marker for liver distress. Elevated GGT is an independent predictor of cardiovascular-related death and stroke. It is often elevated in cases of oxidative stress, which damages blood vessels.
Albumin and Bilirubin
Unlike the enzymes above, which signal injury, these measure the liver’s actual function (its ability to build and clean).
- Albumin: A protein made by the liver that keeps fluid from leaking out of blood vessels. Low levels can indicate chronic liver disease or kidney issues, both of which strain the heart.
- Bilirubin: A waste product from the breakdown of red blood cells. The liver clears this from the body.
Reference Guide: Understanding Your Results
Note: Reference ranges vary by laboratory. Always consult your doctor for interpretation.
Test Marker | Typical Normal Range | What It Means for Metabolic Health |
ALT | 7–55 U/L | High levels suggest liver inflammation and potential insulin resistance. |
AST | 8–48 U/L | Elevation indicates cell damage; often compared with ALT to determine the cause. |
ALP | 40–129 U/L | High levels may signal bile duct obstruction or bone turnover. |
Albumin | 3.5–5.0 g/dL | Low levels suggest the liver isn’t manufacturing enough protein; linked to fluid retention (edema). |
Bilirubin | 0.1–1.2 mg/dL | High levels cause jaundice (yellowing), which indicates processing issues. |
Interpreting Results in the Context of Heart Health
Seeing elevated values on your liver function test can be concerning. It is important to view these results as powerful indicators of systemic cardiovascular risk.
What High Enzymes Mean for Your Arteries
Sustained elevation of enzymes like ALT, AST, and GGT signals chronic metabolic stress and inflammation. This inflammation circulates throughout the body, directly impacting your cardiovascular system.
- Endothelial Damage: Inflammatory signals released by a distressed liver damage the endothelium, the delicate inner lining of your blood vessels. This damage is the first step in plaque formation.
- Accelerated Atherosclerosis: Patients with high liver enzymes, particularly those associated with MASLD, experience accelerated atherosclerosis (hardening and narrowing of the arteries).
- Insulin Resistance: Abnormal liver function is tightly linked to insulin resistance, a core component of metabolic syndrome. This drives the production of harmful triglycerides and small, dense LDL particles, which are highly atherogenic.
When to Worry
Not every abnormal result requires immediate panic. LFTs can be temporarily raised by vigorous exercise, certain common medications, or minor illnesses. However, you should seek immediate follow-up if:
- Elevations are sustained: results remain high after two or three months of retesting, indicating chronic inflammation.
- Symptoms Appear: You experience unexplained fatigue, sudden weight loss, or persistent nausea alongside the elevated numbers.
- Bilirubin is High: Significantly high bilirubin or low albumin signals that the liver’s core functional capacity may be compromised.
Always discuss abnormal liver enzymes with your physician, who can investigate the cause and assess your overall cardiovascular risk.
Improving Liver Function to Boost Heart Health
The good news regarding abnormal liver function test results is that the liver is highly regenerative. Focusing on strategic lifestyle changes can often reverse early-stage inflammation, improving your LFTs and significantly reducing your cardiovascular risk.
Nutritional Strategies
The cornerstone of improving the liver-heart axis lies in what you eat.
- Embrace the Mediterranean Diet: This pattern prioritizes high fiber, whole grains, vegetables, and unsaturated fats (like olive oil and nuts).
- Target Fructose and Sugar: Minimizing sweetened beverages and processed foods is a must, as high sugar intake is a primary driver of fat synthesis in the liver.
- Choose Healthy Fats: Focus on Omega-3 fatty acids, which have anti-inflammatory effects that benefit both the liver and the arteries.
Lifestyle Interventions
Exercise is one of the most potent non-pharmacological treatments for metabolic health.
- Aim for Weight Loss: Losing just 5–10% of your body weight can dramatically decrease liver fat content and improve insulin sensitivity.
- Move Regularly: Aim for 150 minutes of moderate-intensity aerobic exercise per week. Even moderate exercise, independent of weight loss, improves the liver’s ability to process fat.
- Incorporate Resistance Training: Building muscle mass improves overall metabolic function and helps your body manage blood sugar more effectively.
Medical Management
While lifestyle changes are often sufficient, sometimes medical management is necessary.
- Manage Diabetes and Hypertension: Ensuring strict control of blood sugar and blood pressure with prescribed medications, as these conditions accelerate liver and heart damage.
- Consult Before Supplements: Do not begin taking supplements marketed for liver cleansing without consulting your physician. Many popular supplements are ineffective, and some can even cause or worsen liver injury.
Key Takeaways
The liver function test offers helpful insights that extend far beyond the liver itself, acting as a barometer for your overall metabolic and cardiovascular health.
- Metabolic Indicator: Elevated enzymes, particularly ALT and GGT, are strong signals of systemic inflammation. They indicate an increased risk of Metabolically Dysregulated-Associated Steatotic Liver Disease (MASLD) and accelerated atherosclerosis (plaque buildup) in your arteries.
- Heart Health Link: Liver distress impairs the body’s ability to properly regulate cholesterol and fats, making it a key, often overlooked, driver of heart disease risk.
- The Power of Lifestyle: The liver is resilient. Modest weight loss (5–10%), increased physical activity, and a focus on cutting sugars and saturated fats can often normalize LFT results.
- Actionable Advice: Never self-diagnose. Always consult your physician to interpret abnormal liver function test results and establish a comprehensive, personalized plan to protect both your liver and your heart.
- Tsai J, et al. Heart Disease and Stroke Statistics—2024 Update: A Report From the American Heart Association. Circulation. 2024;149(8):e366-e659. https://professional.heart.org/en/science-news/heart-disease-and-stroke-statistics-2024-update
- Rinella ME, et al. A Multisociety Delphi Consensus Statement on New Fatty Liver Disease Nomenclature. Hepatology. 2023;78(7):1982-1988. https://pubmed.ncbi.nlm.nih.gov/37363821/
- Mach F, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111-188. https://academic.oup.com/eurheartj/article-abstract/41/1/111/5556353
- Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010;363(14):1341-50. https://pubmed.ncbi.nlm.nih.gov/20879883/
- Rantala A, et al. Gamma-glutamyltransferase and the risk of coronary heart disease mortality: Causal or confounding association? A prospective cohort study. Atherosclerosis. 2015;241(2):498-503. https://doi.org/10.1016/j.atherosclerosis.2014.12.045
- Vilar-Gomez E, et al. Weight loss through lifestyle modification significantly reduces liver fibrosis in patients with nonalcoholic steatohepatitis. Gastroenterology. 2015;149(2):367-378. https://pubmed.ncbi.nlm.nih.gov/25865049/
- American Heart Association (AHA). Recommendations for Physical Activity. Dallas (TX): AHA; 2021. https://www.heart.org/en/healthy-living/fitness/fitness-basics/aha-recs-for-physical-activity-in-adults
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Treatment for NAFLD & NASH. Bethesda (MD): NIH; 2023. https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash/treatment
- Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis. 2008;28(2):125-140. https://pubmed.ncbi.nlm.nih.gov/18956290/
Frequently Asked Questions (FAQs)
Yes, but often indirectly. Severe, late-stage liver disease (such as cirrhosis) can cause systemic circulatory changes and nutrient imbalances that may lead to arrhythmias or palpitations.
However, mild LFT elevations from MASLD rarely cause them directly. If you experience palpitations, a full cardiovascular workup is essential to rule out primary heart issues.
For the general, healthy public, LFTs are typically included in routine annual physical blood work. If you have known risk factors, such as metabolic syndrome, type 2 diabetes, or a family history of liver disease, your physician may recommend more frequent monitoring, perhaps every six to twelve months, to track the effectiveness of lifestyle interventions.
No, not necessarily. The liver controls most of the body’s cholesterol production, so high cholesterol is often a sign of genetic factors or dietary habits, not direct liver damage.
However, abnormal LFTs alongside high triglycerides and cholesterol strongly suggest metabolic dysfunction, where both the liver and heart are simultaneously at risk.
In many cases, yes. If the abnormality is primarily due to Metabolically Dysfunctional-Associated Steatotic Liver Disease (MASLD), the condition is often highly reversible.
Research shows that weight loss (5–10%), increased physical activity, and key dietary changes can normalize enzyme levels and significantly clear excess fat from the liver, thereby protecting the heart.







































